| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2025 | Dec, 2025 | Dec, 2025 | Dec, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Japan Tobacco (JAPAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Japan Tobacco Inc was incorporated on April 1, 1985. The Company is engaged in the tobacco business. It operates in the following business segments: Japanese Domestic Tobacco business, International Tobacco business, Pharmaceutical business, Beverage business, and Food business. The Domestic Tobacco Business manufactures and sells tobacco products in domestic areas (which include duty-free shops in Japan and markets in China, Hong Kong, and Macau where the Company's China Division operates). The International Tobacco Business manufactures and sells tobacco products overseas mainly through JT International S.A., which controls manufacturing and sales operations. The Pharmaceutical Business consists of research and development, and the manufacture and sale of prescription drugs. The Beverage Business consists of the manufacture and sale of beverages. The Processed Food Business consists of the manufacture and sale of frozen and room-temperature processed foods, bakery products and seasonings.